Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,651 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification and Quantification of Radiotherapy-related Protein Expression in Cancer Tissues Using the Qupath Software and Prediction of Treatment Response.
Hasegawa T, Someya M, Tsuchiya T, Kitagawa M, Fukushima Y, Gocho T, Mafune S, Okuda R, Kaguchi J, Ohguro A, Kamiyama R, Ashina A, Toshima Y, Hirohashi Y, Torigoe T, Sakata KI. Hasegawa T, et al. Among authors: kitagawa m. In Vivo. 2024 May-Jun;38(3):1470-1476. doi: 10.21873/invivo.13593. In Vivo. 2024. PMID: 38688633 Free PMC article.
Influence of XRCC4 expression in esophageal cancer cells on the response to radiotherapy.
Hori M, Someya M, Matsumoto Y, Nakata K, Kitagawa M, Hasegawa T, Tsuchiya T, Fukushima Y, Gocho T, Sato Y, Ohnuma H, Kato J, Sugita S, Hasegawa T, Sakata KI. Hori M, et al. Among authors: kitagawa m. Med Mol Morphol. 2017 Mar;50(1):25-33. doi: 10.1007/s00795-016-0144-5. Epub 2016 Jun 23. Med Mol Morphol. 2017. PMID: 27338590
Expression of Ku70 predicts results of radiotherapy in prostate cancer.
Hasegawa T, Someya M, Hori M, Matsumoto Y, Nakata K, Nojima M, Kitagawa M, Tsuchiya T, Masumori N, Hasegawa T, Sakata KI. Hasegawa T, et al. Among authors: kitagawa m. Strahlenther Onkol. 2017 Jan;193(1):29-37. doi: 10.1007/s00066-016-1023-7. Epub 2016 Jul 27. Strahlenther Onkol. 2017. PMID: 27465041 Clinical Trial. English.
Association between radiotherapy-induced alteration of programmed death ligand 1 and survival in patients with uterine cervical cancer undergoing preoperative radiotherapy.
Tsuchiya T, Someya M, Takada Y, Hasegawa T, Kitagawa M, Fukushima Y, Gocho T, Hori M, Nakata K, Hirohashi Y, Torigoe T, Saito T, Sakata KI. Tsuchiya T, et al. Among authors: kitagawa m. Strahlenther Onkol. 2020 Aug;196(8):725-735. doi: 10.1007/s00066-019-01571-1. Epub 2020 Jan 17. Strahlenther Onkol. 2020. PMID: 31953603
Prediction of treatment response from the microenvironment of tumor immunity in cervical cancer patients treated with chemoradiotherapy.
Someya M, Tsuchiya T, Fukushima Y, Hasegawa T, Hori M, Kitagawa M, Gocho T, Mafune S, Ikeuchi Y, Hirohashi Y, Torigoe T, Iwasaki M, Matsuura M, Saito T, Matsumoto Y, Sakata KI. Someya M, et al. Among authors: kitagawa m. Med Mol Morphol. 2021 Sep;54(3):245-252. doi: 10.1007/s00795-021-00290-w. Epub 2021 May 8. Med Mol Morphol. 2021. PMID: 33963949
Influence of PD-L1 expression in immune cells on the response to radiation therapy in patients with oropharyngeal squamous cell carcinoma.
Fukushima Y, Someya M, Nakata K, Hori M, Kitagawa M, Hasegawa T, Tsuchiya T, Gocho T, Ikeda H, Hirohashi Y, Torigoe T, Sugita S, Hasegawa T, Himi T, Sakata KI. Fukushima Y, et al. Among authors: kitagawa m. Radiother Oncol. 2018 Nov;129(2):409-414. doi: 10.1016/j.radonc.2018.08.023. Epub 2018 Sep 21. Radiother Oncol. 2018. PMID: 30249348
Evaluation of the urethral α/β ratio and tissue repair half-time for iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapy.
Gocho T, Hori M, Fukushima Y, Someya M, Kitagawa M, Hasegawa T, Tsuchiya T, Hareyama M, Takagi M, Hashimoto K, Masumori N, Sakata KI. Gocho T, et al. Among authors: kitagawa m. Brachytherapy. 2020 May-Jun;19(3):290-297. doi: 10.1016/j.brachy.2020.02.007. Epub 2020 Apr 2. Brachytherapy. 2020. PMID: 32249179
1,651 results